Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety, tolerability, and efficacy of BMS-986158 alone and in combination with either Ruxolitinib or Fedratinib in participants with Dynamic International Pr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07281781 · Myelofibrosis, Myelofibrosis; Anemia
NCT07357727 · Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), and more
NCT06773195 · Myelofibrosis
NCT07104799 · Myelofibrosis, Hematopoietic Cell Transplantation (HCT)
NCT06976918 · Primary Myelofibrosis, Secondary Myelofibrosis, and more
Local Institution - 0069
Newport Beach, California
Local Institution - 0090
Lake Mary, Florida
Local Institution - 0043
New Orleans, Louisiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions